Kenvue shares rise as Kimberly-Clark deal spread holds near 2%
Kenvue jumped 1.7% to $18.72, still trading below Kimberly-Clark’s $19.11-per-share cash-and-stock takeover offer, as investors watch for regulatory approval and Tylenol lawsuit risks that could impact the deal’s value and timing.